Skip to Content

MYLAN 472 (Mycophenolate mofetil 500mg)

Pill imprint MYLAN 472 has been identified as Mycophenolate mofetil 500mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; dermatomyositis; systemic lupus erythematosus; myasthenia gravis; organ transplant, rejection prophylaxis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 500mg MYLAN 472
Mycophenolate mofetil 500mg MYLAN 472 Front
Mycophenolate mofetil 500mg MYLAN 472 Back
Mycophenolate mofetil 500mg MYLAN 472
Mycophenolate mofetil 500mg MYLAN 472
Mycophenolate mofetil
Imprint:
MYLAN
472
Strength:
500mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4472
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone
corn starch
ferric oxide red
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferric oxide yellow

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide